Program: Continuing Conversations with the Speakers
Session: Continuing Conversations with the Speakers on Harnessing T cells in Therapy of Hematologic Malignancy
Session: Continuing Conversations with the Speakers on Harnessing T cells in Therapy of Hematologic Malignancy
Sunday, December 6, 2015, 11:15 AM-12:15 PM
W303, Level 3
(Orange County Convention Center)
Disclosures: Sadelain: Juno Therapeutics: Consultancy , Equity Ownership , Other: Co-Founder, stockholder , Patents & Royalties: Licensed patents on CARs .